We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer (Neo-ACET BC)

This study has been terminated.
(Due to an adverse event revelation.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01262274
First Posted: December 17, 2010
Last Update Posted: May 21, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Department of breast and endocrine surgery graduate school of Medicine Osaka University
Information provided by (Responsible Party):
Translational Research Informatics Center, Kobe, Hyogo, Japan
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2014
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)